Chan Zuckerberg Initiative (CZI) announces generous funding for medRxiv to support its mission of helping scientists share health-related research in real time, including critical research on COVID-19.
bioRxiv and medRxiv co-founder Richard Sever discusses how the preprint servers are vital sources of new research results straight from the laboratory in the global effort to fight the COVID-19 pandemic.
bioRxiv and medRxiv co-founder John Inglis contributed advice to a tipsheet for journalists on covering preprints written by Denise-Marie Ordway and published by the Shorenstein Center at Harvard Kennedy School.
On January 20 and 21, 2020, the not-for-profit ASAPbio organization convened a workshop on improving the discoverability, reuse, and interoperability of preprints in the life and biomedical sciences. bioRxiv and medRxiv co-founders John Inglis and Richard Sever and medRxiv co-founder Theo Bloom were among the 30 attendees.